Terminated PHASE4 INTERVENTIONAL 2-arm NCT00613964

The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure

Sponsor: Nara Medical University

Interventions Carperitide heart failure therapy Standard heart failure therapy

Updated 5 times since 2017 Last updated: Jul 20, 2011 Started: May 31, 2009 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other Heart Failure trials with similar outcome

Browse all Heart Failure trials

Listed as NCT00613964, this PHASE4 trial focuses on Heart Failure and Renal Failure and remains terminated or withdrawn. Sponsored by Nara Medical University, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nara Medical University

Data source: Nara Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nara, Japan